查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576807

基因编辑市场：按技术、应用、最终用户、产品和服务、交付方式分类 - 2025-2030 年全球预测

Gene Editing Market by Technology (CRISPR, Meganucleases, TALENs), Application (Agricultural Applications, Clinical Applications, Research Applications), End User, Product & Service, Delivery Method - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年基因编辑市值为78.9亿美元，预计2024年将达到91.8亿美元，复合年增长率为17.81%，到2030年将达到248.7亿美元。

基因编辑被定义为一种对生物体DNA序列进行特定且有意改变的方法，其精确性、效率和广泛的应用在各个领域具有巨大的潜力。对基因编辑的需求源于其解决重要挑战的能力，例如纠正遗传疾病、提高农业生产力以及开发医疗保健领域的新治疗方法。其应用领域广泛，从生物医学研究、农业、药物发现到再生医学，使其成为现代科学的多功能工具。最终用途广泛，包括製药、生物技术、农业和学术研究机构。市场成长的推动因素包括 CRISPR-Cas9 等基因编辑技术的进步、公共和私人资金的增加以及对基因改造作物和基因疗法的需求不断增长。然而，道德问题、监管挑战和高成本是限制快速市场渗透的主要限制因素。此外，CRISPR技术的复杂性和脱靶效应带来了阻碍广泛采用的技术挑战。重大机会在于将应用从传统应用扩展到合成生物学和生质燃料等领域。为了利用这些潜在的机会，公司应该专注于降低成本并提高基因编辑技术的精确度的创新，从而提高其适用性和社会接受度。人工智慧和机器学习相结合来预测基因编辑的结果，以及 CRISPR 文库加速研究的潜力，为创新提供了一个有前景的领域。然而，监管情况因地区而异，因此需要策略导航才能更顺利地进入和采用市场。市场竞争激烈，技术进步迅速，需要不断创新。因此，公共当局、私人公司和监管机构之间的广泛合作对于充分发挥基因编辑技术的潜力并指导道德实施至关重要。

主要市场统计
基准年[2023] 78.9亿美元
预测年份 [2024] 91.8亿美元
预测年份 [2030] 248.7亿美元
复合年增长率（%） 17.81%

市场动态：揭示快速发展的基因编辑市场的关键市场洞察

供需的动态交互作用正在改变基因编辑市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 遗传性疾病和病症的盛行率日益增加，需要创新的治疗解决方案
    • 扩大 CRISPR 和其他先进技术在临床应用中的采用
    • 扩大政府和私营部门对基因组学和基因治疗研究的资助
  • 市场限制因素
    • 基因编辑技术的高成本和伦理问题
  • 市场机会
    • 将基因编辑与人工智慧（AI）等其他先进技术结合
    • 增加基因研究和生物技术的投资，推动基因编辑的进步
  • 市场挑战
    • 与基因编辑相关的技术和伦理问题

波特的五力：驾驭基因编辑市场的策略工具

波特的五力架构是了解基因编辑市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因编辑市场的外部影响

外部宏观环境因素在塑造基因编辑市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因编辑市场的竞争状况

对基因编辑市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV定位矩阵基因编辑市场厂商绩效评估

FPNV定位矩阵是评估基因编辑市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了基因编辑市场的成功之路

基因编辑市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 越来越多的遗传疾病和病症需要创新治疗方法
      • 更多在临床应用中采用 CRISPR 和其他先进技术
      • 扩大政府和私营部门对基因组学和基因治疗研究的资助
    • 抑制因素
      • 基因编辑技术的高成本和伦理问题
    • 机会
      • 将基因编辑与人工智慧（AI）等其他先进技术结合
      • 对基因研究和生物技术的投资增加推动了基因编辑的进步
    • 任务
      • 与基因编辑相关的技术和伦理挑战
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因编辑市场：依技术分类

  • 更脆
  • Meganucleases
  • TALENs
  • 锌指核酸酶 (ZFN)

第七章 基因编辑市场：依应用分类

  • 农业用途
    • 作物改良
    • 家畜基因工程
  • 临床应用
    • 细胞株工程
    • 基因治疗
  • 调查申请
    • 基因功能研究
    • 干细胞研究

第八章 基因编辑市场：依最终使用者划分

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第九章基因编辑市场：依产品/服务分类

  • 消耗品
    • 试剂套件和试剂
    • 图书馆
  • 装置
  • 服务

第10章按交付方式分類的基因编辑市场

  • 生物学方法
    • 非病毒方法
    • 病毒载体
  • 物理方法
    • 电穿孔
    • 显微注射

第十一章美洲基因编辑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区基因编辑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲基因编辑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-535C6291877E

The Gene Editing Market was valued at USD 7.89 billion in 2023, expected to reach USD 9.18 billion in 2024, and is projected to grow at a CAGR of 17.81%, to USD 24.87 billion by 2030.

Gene editing, defined as a method of making specific and intentional changes to the DNA sequence of living organisms, holds immense potential across various sectors due to its precision, efficiency, and broad application scope. The necessity of gene editing is rooted in its ability to address critical challenges, such as correcting genetic disorders, improving agricultural productivity, and developing novel therapies in healthcare. Applications span sectors from biomedical research, agriculture, and drug discovery to regenerative medicine, making it a versatile tool in modern science. End-use scope is vast, including pharmaceuticals, biotechnology, agriculture, and academic research institutions. Market growth is driven by advances in gene-editing technologies like CRISPR-Cas9, increased funding from public and private sectors, and an escalating demand for genetically modified crops and gene therapies. However, ethical concerns, regulatory challenges, and high costs are significant limitations curbing rapid market adoption. Moreover, the complexity of CRISPR technology and off-target effects present technical challenges that hinder widespread use. Key opportunities lie in expanding applications beyond traditional uses to encompass areas like synthetic biology and biofuels. To capitalize on these potential opportunities, businesses should focus on innovations that reduce costs and improve the precision of gene-editing techniques, thus enhancing their applicability and public acceptance. The integration of artificial intelligence and machine learning to predict gene-edited outcomes and potential CRISPR libraries to expedite research offer promising areas of innovation. However, stringent regulatory landscapes across different regions necessitate strategic navigation to enable smoother market entry and adoption. The gene editing market is intensely competitive, characterized by rapid technological advancements and a need for constant innovation. Thus, widespread collaboration between public institutions, private players, and regulatory bodies is essential to harness the full potential and guide ethical implementation of gene-editing technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 7.89 billion
Estimated Year [2024] USD 9.18 billion
Forecast Year [2030] USD 24.87 billion
CAGR (%) 17.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Editing Market

The Gene Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased prevalence of genetic diseases and disorders requiring innovative treatment solutions
    • Growing adoption of CRISPR and other advanced technologies in clinical applications
    • Expanding governmental and private sector funding for genomics and gene therapy research
  • Market Restraints
    • High costs and ethical concerns regarding gene-editing technologies
  • Market Opportunities
    • Integration of gene editing with other advanced technologies such as artificial intelligence (AI)
    • Rising investment in genetic research and biotechnology to drive gene editing advancements
  • Market Challenges
    • Technological and ethical challenges associated with gene editing

Porter's Five Forces: A Strategic Tool for Navigating the Gene Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Editing Market

A detailed market share analysis in the Gene Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Editing Market

A strategic analysis of the Gene Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Bayer CropScience, Beam Therapeutics, Bluebird Bio, Caribou Biosciences, Cellectis, Cibus, CRISPR Therapeutics, Editas Medicine, Genscript Biotech, Horizon Discovery, Inscripta, Intellia Therapeutics, Lonza Group, Pioneer Hi-Bred International Inc., Precision Biosciences, Regeneron Pharmaceuticals, Sangamo Therapeutics, Syngenta AG, Synthego, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across CRISPR, Meganucleases, TALENs, and Zinc Finger Nucleases (ZFNs).
  • Based on Application, market is studied across Agricultural Applications, Clinical Applications, and Research Applications. The Agricultural Applications is further studied across Crop Enhancement and Livestock Genetic Engineering. The Clinical Applications is further studied across Cell Line Engineering and Gene Therapy. The Research Applications is further studied across Gene Function Studies and Stem Cell Research.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Product & Service, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Kits & Reagents and Libraries.
  • Based on Delivery Method, market is studied across Biological Methods and Physical Methods. The Biological Methods is further studied across Non-Viral Methods and Viral Vectors. The Physical Methods is further studied across Electroporation and Microinjection.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased prevalence of genetic diseases and disorders requiring innovative treatment solutions
      • 5.1.1.2. Growing adoption of CRISPR and other advanced technologies in clinical applications
      • 5.1.1.3. Expanding governmental and private sector funding for genomics and gene therapy research
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and ethical concerns regarding gene-editing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of gene editing with other advanced technologies such as artificial intelligence (AI)
      • 5.1.3.2. Rising investment in genetic research and biotechnology to drive gene editing advancements
    • 5.1.4. Challenges
      • 5.1.4.1. Technological and ethical challenges associated with gene editing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Editing Market, by Technology

  • 6.1. Introduction
  • 6.2. CRISPR
  • 6.3. Meganucleases
  • 6.4. TALENs
  • 6.5. Zinc Finger Nucleases (ZFNs)

7. Gene Editing Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural Applications
    • 7.2.1. Crop Enhancement
    • 7.2.2. Livestock Genetic Engineering
  • 7.3. Clinical Applications
    • 7.3.1. Cell Line Engineering
    • 7.3.2. Gene Therapy
  • 7.4. Research Applications
    • 7.4.1. Gene Function Studies
    • 7.4.2. Stem Cell Research

8. Gene Editing Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Gene Editing Market, by Product & Service

  • 9.1. Introduction
  • 9.2. Consumables
    • 9.2.1. Kits & Reagents
    • 9.2.2. Libraries
  • 9.3. Instruments
  • 9.4. Services

10. Gene Editing Market, by Delivery Method

  • 10.1. Introduction
  • 10.2. Biological Methods
    • 10.2.1. Non-Viral Methods
    • 10.2.2. Viral Vectors
  • 10.3. Physical Methods
    • 10.3.1. Electroporation
    • 10.3.2. Microinjection

11. Americas Gene Editing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gene Editing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gene Editing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer CropScience
  • 2. Beam Therapeutics
  • 3. Bluebird Bio
  • 4. Caribou Biosciences
  • 5. Cellectis
  • 6. Cibus
  • 7. CRISPR Therapeutics
  • 8. Editas Medicine
  • 9. Genscript Biotech
  • 10. Horizon Discovery
  • 11. Inscripta
  • 12. Intellia Therapeutics
  • 13. Lonza Group
  • 14. Pioneer Hi-Bred International Inc.
  • 15. Precision Biosciences
  • 16. Regeneron Pharmaceuticals
  • 17. Sangamo Therapeutics
  • 18. Syngenta AG
  • 19. Synthego
  • 20. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE EDITING MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE EDITING MARKET SIZE, BY ZINC FINGER NUCLEASES (ZFNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE EDITING MARKET SIZE, BY CROP ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE EDITING MARKET SIZE, BY LIVESTOCK GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE EDITING MARKET SIZE, BY GENE FUNCTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE EDITING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENE EDITING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENE EDITING MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENE EDITING MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENE EDITING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENE EDITING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENE EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENE EDITING MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 202. SINGAPORE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 224. TAIWAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 235. THAILAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 246. VIETNAM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 269. DENMARK GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. DENMARK GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. DENMARK GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. DENMARK GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 280. EGYPT GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. EGYPT GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. EGYPT GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. EGYPT GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 291. FINLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. FINLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. FINLAND GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. FINLAND GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 302. FRANCE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. FRANCE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. FRANCE GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 305. FRANCE GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 313. GERMANY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. GERMANY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. GERMANY GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 316. GERMANY GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 323. GERMANY GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 324. ISRAEL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. ISRAEL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. ISRAEL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 327. ISRAEL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 328. ISRAEL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 329. ISRAEL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. ISRAEL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 331. ISRAEL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 332. ISRAEL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 333. ISRAEL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 334. ISRAEL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 335. ITALY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 336. ITALY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. ITALY GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 338. ITALY GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 339. ITALY GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 340. ITALY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 341. ITALY GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 342. ITALY GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 343. ITALY GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 344. ITALY GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 345. ITALY GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 346. NETHERLANDS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 347. NETHERLANDS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. NETHERLANDS GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 349. NETHERLANDS GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 350. NETHERLANDS GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 351. NETHERLANDS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 352. NETHERLANDS GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 353. NETHERLANDS GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 354. NETHERLANDS GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 355. NETHERLANDS GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 356. NETHERLANDS GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 357. NIGERIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 358. NIGERIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 359. NIGERIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 360. NIGERIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2